Phillip Eric Lee

Phillip Eric Lee

No más puestos en curso

Fortuna: 322 126 $ al 31/08/2026

39 años
Health Technology
Consumer Services
Finance

Perfil

Phillip Eric Lee formerly worked at Cytokinetics, Inc., as Senior Director from 2015 to 2018, Adverum Biotechnologies, Inc., as Associate Director from 2015 to 2016, 4D Molecular Therapeutics, Inc., as Senior Director & Vice President from 2018 to 2021, Vaxart, Inc., as Chief Financial & Accounting Officer from 2022 to 2025, Centerview Partners LLC, as Principal from 2009 to 2015, and Clover Biopharmaceuticals Ltd., as Chief Financial & Business Development Officer.
Mr. Lee received his undergraduate degree from the University of California, Berkeley.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/03/2025 631.619 ( 0,26 % ) 322 126 $ 31/08/2026

Antiguos cargos conocidos de Phillip Eric Lee.

EmpresasCargoFin
VAXART, INC. Director Financiero/CFO 19/05/2025
CLOVER BIOPHARMACEUTICALS, LTD. Director Financiero/CFO 01/07/2022
4D MOLECULAR THERAPEUTICS, INC. Director/Miembro de la Junta 01/01/2021
CYTOKINETICS, INCORPORATED Director/Miembro de la Junta 01/03/2018
ADVERUM BIOTECHNOLOGIES, INC. Corporate Officer/Principal 01/01/2016
Ver el detalle de la experiencia de Phillip Eric Lee.

Formación de Phillip Eric Lee.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

69

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Phillip Eric Lee